ReviewExpert review of anticancer therapy2013

Tyrosine kinase inhibition: a therapeutic target for the management of chronic-phase chronic myeloid leukemia.

Elias J Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.